Truffle Hound Capital LLC increased its position in eHealth, Inc. (NASDAQ:EHTH - Free Report) by 185.7% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 200,000 shares of the financial services provider's stock after acquiring an additional 130,000 shares during the period. Truffle Hound Capital LLC owned about 0.66% of eHealth worth $1,336,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. American Century Companies Inc. raised its stake in eHealth by 4.0% during the 4th quarter. American Century Companies Inc. now owns 46,422 shares of the financial services provider's stock valued at $436,000 after buying an additional 1,772 shares during the last quarter. Sei Investments Co. increased its stake in shares of eHealth by 5.3% in the 4th quarter. Sei Investments Co. now owns 110,728 shares of the financial services provider's stock worth $1,041,000 after purchasing an additional 5,622 shares in the last quarter. Prudential Financial Inc. purchased a new stake in shares of eHealth in the 4th quarter worth $111,000. JPMorgan Chase & Co. increased its stake in shares of eHealth by 2,348.6% in the 4th quarter. JPMorgan Chase & Co. now owns 97,601 shares of the financial services provider's stock worth $917,000 after purchasing an additional 93,615 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in shares of eHealth in the 4th quarter worth $243,000. 79.54% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on EHTH. Wall Street Zen downgraded shares of eHealth from a "buy" rating to a "hold" rating in a report on Sunday, May 11th. Royal Bank Of Canada reissued a "sector perform" rating and set a $11.00 price objective on shares of eHealth in a report on Monday, May 19th. Finally, UBS Group dropped their price objective on shares of eHealth from $9.50 to $7.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, eHealth has a consensus rating of "Hold" and an average price target of $6.75.
Read Our Latest Stock Analysis on EHTH
eHealth Price Performance
Shares of NASDAQ EHTH traded up $0.04 during mid-day trading on Tuesday, hitting $3.30. 162,461 shares of the company's stock traded hands, compared to its average volume of 325,930. The company's 50-day moving average is $4.04 and its two-hundred day moving average is $6.25. The company has a market capitalization of $100.21 million, a P/E ratio of -3.35 and a beta of 1.06. eHealth, Inc. has a 1 year low of $3.18 and a 1 year high of $11.36.
eHealth (NASDAQ:EHTH - Get Free Report) last announced its earnings results on Wednesday, May 7th. The financial services provider reported ($0.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.08. The firm had revenue of $113.12 million for the quarter, compared to analysts' expectations of $99.46 million. eHealth had a net margin of 4.14% and a return on equity of 2.16%. Equities analysts anticipate that eHealth, Inc. will post -2.17 EPS for the current fiscal year.
eHealth Profile
(
Free Report)
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
Featured Articles

Before you consider eHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eHealth wasn't on the list.
While eHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.